Related by context. All words. (Click for frequent words.) 70 singleton pregnancies 70 parous women 68 nonpregnant 68 ELBW infants 68 asymptomatic hypothyroidism 68 gestational hypertension 68 subclinical hypothyroidism 67 NHANES III 67 perimenopausal women 67 dietary calcium intake 66 nondepressed 66 nulliparous women 66 dysglycemia 66 fetal malformations 65 gestational diabetes mellitus 65 hydroxyvitamin D levels 65 nonobese 65 gonococcal infections 65 lignan intake 65 mIU L 65 URTI 65 fasting triglyceride levels 65 coronary calcification 65 serum concentrations 65 % CI #.#-#.# [003] 65 endometrial hyperplasia 64 singleton pregnancy 64 thyrotropin levels 64 nondiabetic patients 64 polycystic ovary syndrome PCOS 64 retrospective cohort 64 BRCA2 mutation carriers 64 BRCA gene mutations 64 HIV seronegative 64 aged ≥ 64 chlamydial infection 64 mIU ml 64 serum lipid levels 64 CVD mortality 64 advanced neoplasia 64 folate intake 64 prepregnancy BMI 64 multivariable adjusted 64 definite stent thrombosis 64 transferrin saturation 64 perinatal outcomes 64 multiple logistic regression 64 colorectal neoplasia 64 subclinical hyperthyroidism 64 nanograms milliliter 63 placental malaria 63 multivariate analyzes 63 choline intake 63 recurrent VTE 63 umol L 63 preeclamptic 63 pre eclamptic 63 MetS 63 HGPIN 63 plasma homocysteine levels 63 serum estradiol 63 VLBW 63 serum creatinine levels 63 BLLs 63 urinary BPA 63 seropositivity 63 inhaled budesonide 63 amoxicillin clavulanate 63 recurrent miscarriage 63 serum homocysteine 63 HIV uninfected 63 IDDM 63 recurrent venous thromboembolism 63 advanced adenoma 63 posttreatment 63 advanced adenomas 63 plasma folate 63 albumin excretion 63 gestational diabetes mellitus GDM 63 colorectal adenoma 63 uncomplicated pregnancies 63 oestradiol 63 anemia hemoglobin 63 CIN3 63 thyroid hormone levels 63 Heavy menstrual bleeding 63 endometrial thickness 63 liver transplant recipients 63 femoral neck BMD 63 serum retinol 63 CARDIA 63 premenopausal breast cancer 62 β blockers 62 attending antenatal clinics 62 serum selenium 62 VLBW infants 62 testosterone supplementation 62 irregular menstrual cycles 62 HbA 1c levels 62 HER2 expression 62 ertapenem 62 univariate analyzes 62 follicular phase 62 vaccinees 62 folic acid intake 62 μg d 62 flutamide 62 breastfed exclusively 62 relapsed MM 62 depressive symptomatology 62 anovulatory infertility 62 NNRTI resistance 62 micrograms mcg 62 prepubertal 62 folate intakes 62 endometriosis ovarian cysts 62 LNG IUS 62 serum uric acid 62 folate supplementation 62 beta carotene supplementation 62 nulliparous 62 confidence interval #.#-#.# 62 poor metabolizers 62 breastfed infants 62 triacylglycerol concentrations 62 μg L 62 MMSE scores 62 % CI #.#-#.# [008] 62 BMI ≥ 62 slow metabolizers 62 aldosterone antagonist 62 BRCA1 mutation carriers 62 urinary iodine 62 thromboprophylaxis 62 onset diabetes mellitus 62 bilateral oophorectomy 62 HIV HCV coinfected 62 spontaneous preterm delivery 62 chorioamnionitis 62 depot medroxyprogesterone acetate 62 Gestational diabetes affects 62 baseline HbA1c 62 nonfasting 62 pCR 62 thrombophilia 62 spontaneous preterm birth 62 postnatally 62 Low birthweight 62 carotid IMT 62 anovulatory 62 mild gestational diabetes 62 thrombocytopenic 61 #OHD levels 61 oligohydramnios 61 aldosterone antagonists 61 biochemical relapse 61 Wistar rats 61 hip BMD 61 histological subtype 61 highest tertile 61 REYATAZ ritonavir 61 GH deficiency 61 serum vitamin D 61 recurrent UTI 61 TT genotype 61 NNT = 61 ASCUS 61 polytherapy 61 hepatitis C genotype 61 conjugated equine estrogen 61 nmol L. 61 inhibin B 61 Subgroup analyzes 61 dietary intakes 61 SGPT 61 NPH insulin 61 nmol l 61 homocysteine concentrations 61 IUGR 61 tertiles 61 elevated LDH 61 colorectal neoplasms 61 mmol liter 61 CLA supplementation 61 Insulin sensitivity 61 ductal breast cancer 61 sedentary postmenopausal 61 endometrial carcinoma 61 ginkgo biloba extract 61 lowest tertile 61 prevalences 61 nonfasting triglyceride levels 61 ovulatory cycles 61 BENICAR HCT 61 salpingo oophorectomy 61 antibody titer 61 palivizumab 61 induce ovulation 61 born preterm 61 RLS sufferers 61 Swedish Mammography Cohort 61 adenoma recurrence 61 symptomatic fibroids 61 acromegalic patients 61 microalbumin test 61 probiotic supplementation 61 hormone therapy estrogen 61 serum IGF 61 nonobese patients 61 ovulation induction 61 colorectal adenomas 61 alanine aminotransferase ALT 61 invasive ductal 61 salivary cortisol 61 intrapartum 61 carotid stenosis 61 genotypic resistance 61 abnormal Pap test 61 mammographic density 61 ALT elevation 61 elevated CRP 61 elevated ALT 61 vaginal hysterectomy 61 estrogen metabolites 61 antidiabetic medication 61 tertile 61 μg dL 61 cranial irradiation 61 Triglyceride levels 61 fetal chromosomal 61 serum TSH 61 venlafaxine Effexor 60 folic acid supplement 60 paroxetine Paxil 60 THIS STUDY 60 prepregnancy 60 maternal serum 60 glycated hemoglobin levels 60 #mg/dL [001] 60 tibolone 60 cerebral microbleeds 60 TEAEs 60 overactive bladder symptoms 60 birthweight 60 Health Initiative Observational 60 prostate cancer CaP 60 colorectal cancer incidence 60 nondiabetic 60 observational cohort 60 neoplasias 60 HbA1C levels 60 psychiatric outpatients 60 BRCA1 mutations 60 subfertile 60 NHANES #-# 60 nonvertebral fractures 60 nonexposed 60 obstetric complications 60 #μg [001] 60 preterm deliveries 60 iron supplementation 60 serum urate levels 60 basal cell nevus syndrome 60 calcium supplementation 60 Schaffir 60 serodiscordant couples 60 antiphospholipid antibodies 60 varicocele 60 adolescent females 60 euthyroid 60 BRCA mutation carriers 60 antidiabetic medications 60 mg BID dose 60 tuberculin skin testing 60 underwent bariatric surgery 60 REYATAZ r arm 60 urine albumin 60 preoperative PSA 60 microalbumin 60 Baseline characteristics 60 elective caesarean section 60 AOR = 60 undergone hysterectomies 60 alanine aminotransferase 60 gallstone disease 60 CI -#.# 60 transaminase elevations 60 lipid elevations 60 Vitamin D deficient 60 bivariate analyzes 60 parous 60 pyelonephritis 60 underwent CABG 60 mL/min/#.# m 2 60 thyroid stimulating hormone 60 CHD mortality 60 iPrEx study 60 pre menopausal 60 diverticular bleeding 60 PSA nadir 60 atypical ductal hyperplasia 60 posttransplant 60 polyp recurrence 60 multivitamin supplements 60 hsCRP levels 60 GSTT1 60 EDSS score 60 hypothalamic amenorrhea 60 abdominal ultrasounds 60 osteopenic 60 abdominal adiposity 60 CIN2 + 60 histologic subtype 60 Digital Mammographic Imaging 60 urolithiasis 60 antihypertensive medication 60 norethindrone 60 Amniocentesis 60 microg 60 serum folate 60 postintervention 60 CYP#D# inhibitor 60 % Confidence Interval 60 bronchopulmonary dysplasia 60 randomized controlled trials RCTs 60 sleeve lobectomy 60 low birthweight infants 60 T1DM 59 candidemia 59 odds ratios ORs 59 % CI #.#-#.# [004] 59 adenoma 59 mcg albinterferon alfa 2b 59 renal cell carcinomas 59 dose clopidogrel 59 overt hypothyroidism 59 nmol L 59 ABCB1 59 interquartile range 59 adiponectin levels 59 transfusion syndrome 59 premenopausal 59 chronic prostatitis 59 Wisconsin Sleep Cohort 59 lipid lowering agents 59 nondiabetics 59 postexposure prophylaxis 59 systolic blood pressures 59 serum ferritin 59 congenital toxoplasmosis 59 grade cervical intraepithelial 59 initiating antiretroviral therapy 59 UGT#A# * 59 virologic failure 59 suicide attempters 59 adiponectin concentrations 59 epithelial ovarian cancer 59 anticonvulsant medications 59 magnesium intake 59 univariate analysis 59 antioxidant supplementation 59 aOR 59 logistic regression model 59 GnRH agonists 59 perioperative mortality 59 orofacial clefts 59 IPAH 59 Hb A1C 59 atherogenic dyslipidemia 59 subtrochanteric 59 ovarian carcinoma 59 AMOR IPAT 59 SRBD 59 prehypertensive 59 nonpregnant adults 59 coinfection 59 cesarean births 59 invasive prenatal 59 preintervention 59 estimated GFR 59 urinary albumin 59 cTnT 59 adjunctive placebo 59 primary ovarian insufficiency 59 adnexal mass 59 hyperemesis gravidarum 59 pyloric stenosis 59 acrylamide intake 59 latent celiac disease 59 ALT flares 59 #mg/day [001] 59 creatine supplementation 59 TMP SMX 59 postmenopausal hormone 59 trivalent inactivated influenza 59 atrophic gastritis 59 Framingham Offspring Study 59 monoinfected patients 59 penile vaginal intercourse 59 neutrophil counts 59 hormone estradiol 59 HIV seropositive 59 familial aggregation 59 prolactin levels 59 elevated serum creatinine 59 elevated triglyceride levels 59 hepatorenal syndrome 59 serous ovarian cancer 59 multivariable analyzes 59 rFSH 59 bowel polyps 59 Homocysteine levels 59 Calcium intake 59 iron deficient 59 undergoing bariatric surgery 59 abnormal cytology 59 asymptomatic bacteriuria 59 Arch Intern Med 59 HPV subtypes 59 neurodevelopmental outcome 59 selenium intake 59 Postoperative complications 59 singleton babies 59 logistic regression analysis 59 carbohydrate oxidation 59 neurodevelopmental impairment 59 folate concentrations 59 premenopausal women 59 hemodynamically significant 59 aspartate aminotransferase AST 59 ß carotene 59 intravenous bisphosphonates 59 elevated LDL cholesterol 59 phthalate metabolites 59 bacterial vaginosis BV 59 SLNB 59 PPSV# 59 Cochrane reviewers 59 artery calcification 59 lipid lowering therapy 59 COPD exacerbation 59 BMI z 59 severe periodontitis 59 azoospermia 59 triglyceride concentrations 59 psychiatric comorbidities 59 lipid lowering drugs 59 estimated glomerular filtration 59 â ‰ ¥ 59 mild analgesics 59 ß blockers 59 oophorectomy 59 gross hematuria 59 lifetime abstainers 59 atypical hyperplasia 59 CMV infection 59 Complication rates 59 amenorrhoea 59 cervical intraepithelial neoplasia 59 cTnT levels 59 quadrivalent HPV vaccine 59 abacavir Ziagen 59 aneuploidy screening 59 clomipramine 59 caspofungin 59 vitamin D intakes 59 thyrotropin 59 ENDOMETRIN 59 urinary calcium 59 fibroids endometriosis 59 per deciliter mg 59 plasma lipid 59 non adjuvanted vaccines 59 DHA supplementation 59 isoflavone intake 59 perioperatively 59 CLINICAL STUDIES 59 leiomyomas 59 nonsignificant difference 59 baseline serum creatinine 59 intact parathyroid hormone 59 evaluable subjects 59 CIN2 59 thiazide diuretics 59 autoantibody positive 59 NIHSS 59 precancerous cervical 59 Skin sterol 59 malignant neoplasm 59 L. reuteri 59 endometrial cancers 59 #.#ng/ml 59 nadroparin 59 neurodevelopmental outcomes 59 baseline LDH 58 glomerular filtration 58 quadrivalent vaccine 58 CARDIA study 58 % CI #.#-#.# [007] 58 plasma homocysteine 58 operable breast cancer 58 tumor histology 58 #OHD 58 μmol L 58 differentially expressed genes 58 p = .# [002] 58 salmeterol fluticasone propionate 58 serologic testing 58 micronutrient supplements 58 adenotonsillectomy 58 TOPAMAX ® 58 DAS# CRP 58 AVODART 58 beta blocker therapy 58 fraternal twin pairs 58 antenatal depression 58 ergocalciferol 58 PHPT 58 mg/m2 dose 58 abnormal Pap smear 58 recurrent miscarriages 58 menthol smokers 58 vertebral fracture 58 rs# [001] 58 mineral density 58 affective disorders 58 fluvastatin 58 undetectable HBV DNA 58 obese postmenopausal 58 μg liter 58 adjunctive ABILIFY 58 undergone radical prostatectomy 58 aortic atherosclerosis 58 waist circumferences 58 acellular pertussis DTaP 58 SE alleles 58 atypical antipsychotic medications 58 androgen deficiency 58 intracerebral hemorrhages 58 primary aldosteronism 58 serum IgE 58 ml kg 58 zidovudine lamivudine 58 HBeAg negative patients 58 Poisson regression 58 birthweights 58 prenatal exposures 58 YPDP 58 glulisine 58 airway responsiveness 58 thyroid dysfunction 58 serum leptin 58 benazepril 58 orchitis 58 intraventricular hemorrhage 58 Meta analyzes 58 monozygotic twin 58 plasma cortisol 58 nevirapine Viramune 58 BRCA2 mutations 58 loop diuretics 58 % CI #.#-#.# [006] 58 nmol 58 elevated depressive symptoms 58 underwent radical prostatectomy 58 subclinical atherosclerosis 58 mass indexes BMIs 58 invasive carcinoma 58 RBC folate 58 timepoints 58 undergoing radical prostatectomy 58 postmenopausal hormones 58 endometrial biopsy 58 Univariate analysis 58 pharyngeal cancer 58 postmenopausal breast cancer 58 venous thrombosis 58 hypovitaminosis D 58 Inhibin B 58 HER2 positive cancers 58 DRB1 * 58 ovariectomized 58 lobular breast cancer 58 creatinine ratio 58 antiepileptic drugs AEDs 58 generalized edema 58 pelvic girdle pain 58 valacyclovir 58 BCG vaccinated 58 fasting glucose levels 58 nonfatal MI 58 ABC/3TC 58 systemic corticosteroid 58 amenorrhea 58 Adjuvant chemotherapy 58 DMPA 58 elevated troponin 58 hyperandrogenism 58 colorectal polyp 58 habitual snoring 58 HBeAg positive patients 58 testicular tumors 58 Young Adults CARDIA 58 CANCIDAS 58 Premenopausal women 58 Reynolds Risk Score 58 hematopoietic cancers 58 fasting insulin 58 plasma selenium 58 mg Proellex 58 HDL2 58 BRCA mutations 58 serum calcium 58 NATRECOR ® 58 oxycodone IR 58 oocytes retrieved 58 kg m² 58 cells uL 58 lamotrigine 58 serum calcium levels 58 pimecrolimus cream 58 shorter telomere length 58 elevated hsCRP 58 RhD negative 58 multivariable analysis 58 Subgroup analysis 58 fetuin 58 lymphocyte count 58 abnormal mammograms 58 microgram dose 58 LV dysfunction 58 myocardial infarctions MIs 58 cryptorchidism 58 anti HBs 58 nephrolithiasis 58 nonfasting triglycerides 58 C#BL/#J mice 58 mycophenolate mofetil 58 Prehypertension 58 FeNO 58 abnormal lipid levels 58 KRAS mutations occur 58 coronary artery calcification 58 ovulatory 58 carbohydrate intolerance 58 normal birthweight 58 upper endoscopy 58 intramuscular dose 58 GSTM1 58 conjugated estrogens 58 adjuvant endocrine therapy 58 dizygotic 58 Aspergillus infections 58 enamel defects 58 cervical vaginal 58 ELBW 58 abnormal lipid 58 hMG 58 premenstrual syndrome PMS 58 #mmHg [001] 58 asthma exacerbation 58 hypophosphatemia 58 serum testosterone 58 BRCA mutation 58 polycystic ovary syndrome 58 Postmenopausal 58 PPCM 58 narcolepsy cataplexy 58 arterial thickening 58 genital HPV infection 58 HER2 amplification 58 chlorthalidone 58 familial clustering 58 alpha amylase 58 calculated creatinine clearance 58 NATRECOR R 58 uninfected infants 58 monozygotic 58 antibody titres 58 troponin T 58 plasma triglycerides 58 neural tube birth defects 58 duplex ultrasonography 58 NLSY 58 postoperative mortality 58 kaempferol 58 hemoglobin A1c levels 58 epidural analgesia 58 hepatectomy 58 nonmelanoma skin cancer 58 Cesarean deliveries 58 Caloric intake 58 preterm newborns 58 Human Papillomavirus Quadrivalent Types 58 APOE e4 58 #.#mg/dL 58 logistic regression analyzes 58 cervical lesions 58 p = #.# [003] 58 CI #.#-#.# [002] 58 arterial thromboembolic events 58 hormone receptor status 58 deliver vaginally 58 intra uterine 58 HBeAg 58 μg kg 58 logistic regression models 58 longitudinal cohort study 58 persistent wheezing 58 inhibin 58 plasma adiponectin 58 Immune responses 58 thiazides 57 LRTI 57 fosamprenavir 57 CC genotype 57 abnormal Pap smears 57 hypogonadal 57 inflammatory biomarkers 57 MMSE score 57 retrograde ejaculation 57 Apgar scores 57 BRCA carriers 57 periprocedural 57 axillary lymph nodes 57 PREZISTA r arm 57 pentoxifylline 57 osteoporotic vertebral compression fractures 57 methacholine challenge 57 -#.# log# 57 atorvastatin #mg 57 attain statistical significance 57 ticlopidine 57 diagnosed prenatally 57 progesterone receptor negative 57 ursodeoxycholic acid 57 spontaneous preterm births 57 HBeAg seroconversion 57 median survivals 57 pmol L 57 hypocaloric diet 57 fasting triglycerides 57 nonmelanoma skin cancers 57 dizygotic twins 57 cilostazol 57 telomere lengths 57 intrauterine contraception 57 steroid dexamethasone 57 venous blood clots 57 micromoles 57 chronic periodontitis 57 hormone receptor negative 57 serum cortisol 57 hypoglycemic episodes 57 #ng/ml 57 recurrent wheezing 57 dysfunctional voiding 57 extracolonic findings 57 Progestin 57 DEXA scan 57 non pledgers 57 folate deficiency 57 vitamin D inadequacy 57 dysmenorrhoea 57 obese adolescents 57 abdominal circumference 57 histologically proven 57 methotrexate monotherapy 57 antihypertensive medications 57 microscopic hematuria 57 CLBP 57 adenomatous polyps 57 paraoxonase 57 lobular cancer 57 ìg 57 FluCAM arm 57 lymphoma subtypes 57 kcal d 57 hemoglobin A1c HbA1c 57 bioavailable testosterone 57 ARB telmisartan 57 Vitamin D supplementation 57 Vitamin D supplements 57 indinavir 57 seroconverted 57 rizatriptan 57 dalteparin 57 ng dL 57 del 5q MDS 57 Multiple logistic regression 57 vesicoureteral reflux 57 serum PSA 57 heterozygotes 57 lipid parameters 57 carotid plaques 57 impaired glucose metabolism 57 PUFA intake 57 fructose sweetened beverages 57 IM progesterone 57 serum triglycerides 57 pulmonary dysfunction 57 nitrofurantoins 57 persistent pulmonary hypertension 57 Kaplan Meier analysis 57 genital HSV 57 underwent brachytherapy 57 DHEA supplementation 57 MULTAQ 57 triiodothyronine 57 chest radiographs 57 System IPSS 57 creatinine clearance 57 postmenopausal women 57 external genital lesions 57 urinary oxalate 57 androgen deprivation 57 sonographically guided 57 indexes BMIs 57 multivariate logistic regression 57 oxycodone CR 57 serum parathyroid hormone 57 detemir 57 impaired fasting glucose 57 antioxidant vitamin supplements 57 postpartum hemorrhage 57 GARDASIL ® 57 antiviral prophylaxis 57 CR nPR 57 HBsAg 57 weeks gestation 57 Intrauterine devices 57 containing drospirenone 57 BRCA2 mutation 57 non adjuvanted vaccine 57 Logistic regression analysis 57 sociodemographic characteristics 57 gonadotropins 57 lipid lowering medications 57 tHcy 57 neurologic complications 57 ovarian hormones 57 distal colon cancer 57 hyperemesis 57 achieved ACR# 57 timepoint 57 HBV genotype 57 exposed prenatally 57 IVF ICSI 57 conventional angiography 57 mmol l 57 antiretroviral naïve 57 Squamous 57 glucose tolerance test 57 lumbar spine BMD 57 prenatally diagnosed 57 MenACWY CRM 57 histologically confirmed 57 BMPR2 57 Avandia Actos 57 Epidemiologic studies 57 pT3 57 pelvic lymphadenectomy 57 stone formers 57 gene APOE 57 infantile colic 57 tricyclic antidepressants 57 limiting generalizability 57 tHcy concentrations 57 confidence interval CI 57 MGUS 57 SCIg 57 haloperidol Haldol 57 noncardiac 57 de ath 57 subgroup analyzes 57 hemoglobin concentrations 57 glomerular filtration rate 57 fasting serum 57 anal incontinence 57 malignant polyps 57 thigh circumference 57 paricalcitol 57 singleton births 57 Doxil ® 57 GnRH agonist 57 preterm neonates 57 menstrual disorders 57 corrected QT interval 57 Cochrane Systematic Review 57 placebo controlled studies 57 anal cancers 57 PON1 activity 57 nonnucleoside reverse transcriptase inhibitors 57 COMT genotype 57 dietary questionnaires 57 OGTT 57 phylloquinone 57 BRCA2 carriers 57 thromboembolism 57 HbA1C 57 Multicenter AIDS 57 spirometric 57 Fasting blood glucose 57 epididymitis 57 folate vitamin B 57 statistical significance p 57 CrCl 57 inversely associated 57 lipid abnormalities 57 nonvertebral fracture 57 nonsevere 57 mU L 57 levonorgestrel releasing 57 estrogen progestin therapy 57 antiandrogens 57 congenital adrenal hyperplasia CAH 57 abacavir lamivudine 57 LYSTEDA 57 gonococcal infection 57 multivitamin supplementation 57 EDSS scores 57 folic acid supplementation 57 metabolizer 57 nonmetastatic 57 perfluorooctanoate PFOA 57 atopic asthma 57 handgrip strength 57 Multivariate analysis 57 postmenopausal 57 vaginal lesions 57 conditional logistic regression 57 hormone therapy HT 57 RCTs 57 HRQL 57 chronic HBV 57 receiving antiretroviral therapy 57 CsA 57 renal biopsy 57 recombinant FSH 57 dietary fiber intake 57 ritonavir boosted lopinavir 57 #F FDG PET 57 FTO variant 57 certolizumab 57 Viread Emtriva 57 preoperative chemotherapy 57 postmenopausal hormone replacement 57 neurologic outcomes 57 FDA defined valvulopathy 57 statin monotherapy 57 serum phosphate 57 Eur J Endocrinol 57 antibiotic prophylaxis 57 VADT 57 albumin excretion rate 57 analgesic medications 57 body fatness 57 isoprostane 57 fragility fracture 57 seroprotection 57 pg ml 57 nanomoles per 57 IgA deficiency 57 strontium ranelate 57 variant alleles 57 lopinavir r arm 57 prospective longitudinal 57 autonomic dysfunction 57 HAART regimen 57 Zyban bupropion 57 extrapyramidal symptoms 57 irregular menses 57 sodium valproate 57 VUR 57 N telopeptide 57 protease inhibitor PI 57 ARIXTRA 57 spine BMD 57 sonographic examinations 57 Breastfed babies 57 flavonoid intake 57 multivariate adjustment 56 multivariate Cox 56 covariate 56 A. Beydoun 56 familial pancreatic cancer 56 SHBG levels 56 protein excretion 56 dapagliflozin plus 56 hydroxychloroquine 56 macrosomia 56 cardio respiratory fitness 56 confidence intervals CIs 56 cryptogenic 56 Dietary Modification Trial 56 penetrance 56 MCV4 56 mild renal insufficiency 56 estrogen receptor negative